成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester Struktur
2309122-41-4
CAS-Nr.
2309122-41-4
Englisch Name:
8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester
Synonyma:
8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid;8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester
CBNumber:
CB08124124
Summenformel:
C13H19NO4
Molgewicht:
253.29
MOL-Datei:
2309122-41-4.mol

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester Eigenschaften

Siedepunkt:
389.7±42.0 °C(Predicted)
Dichte
1.237±0.06 g/cm3(Predicted)
pka
4.57±0.20(Predicted)

Sicherheit

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester Chemische Eigenschaften,Einsatz,Produktion Methoden

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
 1461866103@qq.com China 16111 58
Block Chemical Technology (Shanghai) Co., Ltd. 021-20432219 13918097649
 li_jinfei@acblock-lab.com China 10034 58
Shanghai New Bo Biomedical Technology Co., LTD 15821600833
 muyouren139@163.com China 275 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 13327728092
 sales@pharmablock.com China 9698 58
Nantong Hanfang Biotechnology Co. , Ltd. hanfangpharma@126.com; 18616537568
 hanfangpharma@126.com China 29981 58
  • 8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester
  • 8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid
  • 2309122-41-4
Copyright 2019 ? ChemicalBook. All rights reserved